Novo Holdings contributes to USD 540m investment in US health platform

US health platform Noom has secured more than USD 540m in a new financing round in which Novo Holdings participated.

Photo: Novo Holdings / PR

Novo Nordisk owner Novo Holdings has posted a capital injection into US health platform Noom.

This is part of a series F financing round which will bring in USD 540m to the New York-based company.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Sanofi reduces US insulin prices for the uninsured

While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.

Further reading

Related articles

Latest news

See all jobs